The Scientist Magazine®
  • News & Opinion
  • Magazine
  • Current Issue
  • Archives
  • Features
  • Infographics
  • Top 10 Innovations
  • Subjects
  • Cancer Biology
  • Careers
  • Cell & Molecular Biology
  • Clinical Research
  • Coronavirus
  • Disease & Medicine
  • Ecology & Environment
  • Evolution
  • Genetics & Genomics
  • History
  • Immunology
  • Microbiology
  • Neuroscience
  • Obituaries
  • Paleontology
  • Pharma & Biotech
  • Policy
  • Profile
  • Publishing
  • Research Integrity
  • Techniques
  • Multimedia
  • Infographics
  • Image of the Day
  • Crossword Puzzles
  • Videos
  • Research Resources
  • Webinars
  • The Scientist University
  • eBooks
  • Podcasts
  • Research Products Blog
  • Infographics
  • Videos
  • Subscribe
    1. Home
    2. Videos

    Superbugs Ascending

    University of Texas at San Antonio microbiologist Karl Klose discusses the problem of antibiotic resistance in a 2013 TEDx talk.

    Bob Grant
    Bob Grant
    Mar 31, 2014

    Read the full story.

    Keywords:

    antibiotic resistance
    drug development
    Related Articles
    Synthego Launches Eclipse Platform to Accelerate Research and Development of Next-generation MedicinesSynthego Launches Eclipse Platform to Accelerate Research and Development of Next-generation Medicines
    Synthego Launches Eclipse Platform to Accelerate Research and Development of Next-generation Medicines
    Synthego Launches Eclipse Platform to Accelerate Research and Development of Next-generation Medicines
    Pharma Looks to Inflammasome Inhibitors as All-Around TherapiesPharma Looks to Inflammasome Inhibitors as All-Around TherapiesPharma Looks to Inflammasome Inhibitors as All-Around Therapies
    Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
    Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
    Technique Talk: Optimizing PCR Quality and YieldTechnique Talk: Optimizing PCR Quality and YieldTechnique Talk: Optimizing PCR Quality and Yield
    Technique Talk: Optimizing PCR Quality and Yield
    Technique Talk: Optimizing PCR Quality and Yield
    Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case StudySecuring the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case StudySecuring the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
    Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
    Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
    Stay Connected with

    E-Newsletter Sign-up

    Facebook Pages

  • The Scientist
  • Cancer and Genomic Science
  • Cell and Microbial Science
  • The NeuroScientist
  • The Scientist Careers
  • About & Contact
  • Editorial Advisory Board
  • Editorial Policies
  • Privacy Policy
  • Job Listings
  • Subscribe
  • Advertise
    • Now part of the LabX Media Group:Lab Manager Magazine|LabX|LabWrench

    © 1986–2021 The Scientist. All rights reserved.